MedTrace Logo

Pain, Physical Activity, Posture and Quality of Life in Post-COVID-19 Individuals With Idiopathic Scoliosis

NCT06006897 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2025-05-25

No results posted yet for this study

Summary

It is not known to what extent the COVID-19 virus affects individuals with scoliosis during the prolonged COVID-19 pandemic. Therefore, in this study it was aimed to comparatively investigate pain severity, posture disorders that can be assessed by artificial intelligence, physical activity levels and quality of life in individuals with idiopathic scoliosis with and without COVID-19.

Conditions

  • COVID-19 Respiratory Infection
  • Idiopathic Scoliosis

Interventions

OTHER

Physical Evaluations of post-COVID-19 individuals

In this study, scoliosis degree measurement, number of steps, pain, posture and quality of life will be evaluated in idiopathic scoliosis with post-COVID-19 individuals. The data to be obtained from all these evaluations will be collected from the individuals at one time and over a period of approximately 1 hour at the most. Step count tracking with pedometer will be done for each individual for 3 days.

OTHER

Physical evaluations of non-post-COVID-19 individuals

In this study, scoliosis degree measurement, number of steps, pain, posture and quality of life will be evaluated in idiopathic scoliosis without post-COVID-19 individuals.

Sponsors & Collaborators

  • Izmir Democracy University

    lead OTHER

Principal Investigators

  • GÜLŞAH BARĞI · Izmir Democracy University

  • MERVE NUR YÜKSEL · Izmir Democracy University

  • ALİ ERTUĞRUL · Balikesir Ataturk City Hospital

  • RUKİYE YAZICI · Atatürk, Balikesir State Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-16
Primary Completion
2024-09-30
Completion
2024-12-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06006897 on ClinicalTrials.gov